XML 22 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2022   75,670,000      
Beginning balance at Dec. 31, 2022 $ 165,420 $ 76 $ 279,552 $ (115,893) $ 1,685
Increase (Decrease) in Stockholders' Equity          
Exercise of options (in shares)   166,000      
Exercise of options 209 $ 0 209    
Stock based compensation expense 365   365    
Non-controlling shareholder contribution 980       980
Net income (loss) 53,813     53,863 (50)
Ending balance (in shares) at Mar. 31, 2023   75,836,000      
Ending balance at Mar. 31, 2023 220,787 $ 76 280,126 (62,030) 2,615
Beginning balance (in shares) at Dec. 31, 2022   75,670,000      
Beginning balance at Dec. 31, 2022 165,420 $ 76 279,552 (115,893) 1,685
Increase (Decrease) in Stockholders' Equity          
Exercise of options (in shares)   400,000      
Net income (loss) (27,641)        
Ending balance (in shares) at Jun. 30, 2023   93,237,000      
Ending balance at Jun. 30, 2023 241,490 $ 93 381,776 (143,431) 3,052
Beginning balance (in shares) at Mar. 31, 2023   75,836,000      
Beginning balance at Mar. 31, 2023 220,787 $ 76 280,126 (62,030) 2,615
Increase (Decrease) in Stockholders' Equity          
Exercise of options (in shares)   195,000      
Exercise of options 169   169    
Stock based compensation expense 368   368    
Non-controlling shareholder contribution 490       490
Senior Note converted (in shares)   17,206,000      
Senior Note converted 101,130 $ 17 101,113    
Net income (loss) (81,454)     (81,401) (53)
Ending balance (in shares) at Jun. 30, 2023   93,237,000      
Ending balance at Jun. 30, 2023 241,490 $ 93 381,776 (143,431) 3,052
Increase (Decrease) in Stockholders' Equity          
Additional paid-in capital 383,632        
Beginning balance (in shares) at Dec. 31, 2023   93,515,000      
Beginning balance at Dec. 31, 2023 200,387 $ 94 383,632 (187,379) 4,040
Increase (Decrease) in Stockholders' Equity          
Stock based compensation expense 431   431    
Net income (loss) (17,854)     (17,734) (120)
Ending balance (in shares) at Mar. 31, 2024   93,515,000      
Ending balance at Mar. 31, 2024 182,964 $ 94 384,063 (205,113) 3,920
Beginning balance (in shares) at Dec. 31, 2023   93,515,000      
Beginning balance at Dec. 31, 2023 200,387 $ 94 383,632 (187,379) 4,040
Increase (Decrease) in Stockholders' Equity          
Net income (loss) (71,699)        
Ending balance (in shares) at Jun. 30, 2024   93,515,000      
Ending balance at Jun. 30, 2024 129,549 $ 94 384,493 (258,886) 3,848
Beginning balance (in shares) at Mar. 31, 2024   93,515,000      
Beginning balance at Mar. 31, 2024 182,964 $ 94 384,063 (205,113) 3,920
Increase (Decrease) in Stockholders' Equity          
Stock based compensation expense 430   430    
Net income (loss) (53,845)     (53,773) (72)
Ending balance (in shares) at Jun. 30, 2024   93,515,000      
Ending balance at Jun. 30, 2024 129,549 $ 94 $ 384,493 $ (258,886) $ 3,848
Increase (Decrease) in Stockholders' Equity          
Additional paid-in capital $ 384,493